Related references
Note: Only part of the references are listed.Diabetic Retinopathy: A Position Statement by the American Diabetes Association
Sharon D. Solomon et al.
DIABETES CARE (2017)
Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
Emily Y. Chew et al.
DIABETES CARE (2016)
Nine-Year Effects of 3.7 Years of Intensive Glycemic Control on Cardiovascular Outcomes
Hertzel C. Gerstein et al.
DIABETES CARE (2016)
Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial
Hertzel C. Gerstein et al.
LANCET (2014)
Changes in Diabetes-Related Complications in the United States, 1990-2010
Edward W. Gregg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy
Elisabet Agardh et al.
DIABETES CARE (2011)
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
William C. Cushman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII The Twenty-Five-Year Progression of Retinopathy in Persons with Type 1 Diabetes
Ronald Klein et al.
OPHTHALMOLOGY (2008)
Action to control cardiovascular risk in diabetes (ACCORD) trial: Design and methods
John B. Buse
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Glycemia treatment strategies in the action to control cardiovascular risk in diabetes (ACCORD) trial
Hertzel C. Gerstein et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study
N Younis et al.
LANCET (2003)
Share Paper
